Display options
Cite
Jamali AN, Aqil M, Alam MS, et al. A pharmacovigilance study on patients of bronchial asthma in a teaching hospital. J Pharm Bioallied Sci. 2010;2(4):333-6doi: 10.4103/0975-7406.72135.
Jamali, A. N., Aqil, M., Alam, M. S., Pillai, K. K., & Kapur, P. (2010). A pharmacovigilance study on patients of bronchial asthma in a teaching hospital. Journal of pharmacy & bioallied sciences, 2(4), 333-6. https://doi.org/10.4103/0975-7406.72135
Jamali, A N, et al. "A pharmacovigilance study on patients of bronchial asthma in a teaching hospital." Journal of pharmacy & bioallied sciences vol. 2,4 (2010): 333-6. doi: https://doi.org/10.4103/0975-7406.72135
Jamali AN, Aqil M, Alam MS, Pillai KK, Kapur P. A pharmacovigilance study on patients of bronchial asthma in a teaching hospital. J Pharm Bioallied Sci. 2010 Oct;2(4):333-6. doi: 10.4103/0975-7406.72135. PMID: 21180467; PMCID: PMC2996060.
Copy Download .nbib Format: NLM
Share it on

J Pharm Bioallied Sci. 2010 Oct;2(4):333-6. doi: 10.4103/0975-7406.72135.

A pharmacovigilance study on patients of bronchial asthma in a teaching hospital.

Journal of pharmacy & bioallied sciences

A N Jamali, M Aqil, M S Alam, K K Pillai, P Kapur

Affiliations

  1. Department of Pharmacy Practice (Pharmacology), New Delhi - 110 062, India.

PMID: 21180467 PMCID: PMC2996060 DOI: 10.4103/0975-7406.72135

Abstract

OBJECTIVE: The present study was conducted to monitor adverse drug reactions in patients of bronchial asthma in outpatient department and inpatient department of a university teaching hospital in South Delhi.

MATERIALS AND METHODS: About 200 patients irrespective of age and sex with established asthma were interviewed during the time period of January 2006 to April 2006 using structured questionnaire. Naranjo's adverse drug reaction probability scale was used to assess the adverse drug reactions.

RESULTS: A total of 15 adverse drug reactions were reported in 13 out of 200 asthmatic patients. Among the 13 patients reported with adverse drug reactions, 5 (38.5%) were male and 8 (61.5%) patients were female. Maximum percentage of ADRs (2 in 15 prescriptions, 13.3%) observed with montelukast, followed by beclomethasone (1 in 12 prescriptions, 8.3%), salbutamol (6 in 109 prescriptions, 5.5%), and ipratropium (3 in 63 prescriptions, 4.8%).

CONCLUSIONS: Montelukast was found to be associated with greater percentage of adverse drug reactions as compared to other antiasthamatics. The above findings are constrained by a small sample size and need to be corroborated by conducting long-term studies using a larger sample size.

Keywords: Adverse drug reaction; adverse drug reaction monitoring; antiasthmatic; bronchial asthma; pharmacovigilance

References

  1. Allergy. 2004 May;59(5):469-78 - PubMed
  2. Clin Pharmacol Ther. 1981 Aug;30(2):239-45 - PubMed
  3. Clin Exp Allergy. 1998 Sep;28 Suppl 4:61-2 - PubMed
  4. Chest. 2005 Jun;127(6):2057-63 - PubMed
  5. Pharm World Sci. 2004 Jun;26(3):155-9 - PubMed
  6. Mayo Clin Proc. 2002 May;77(5):437-45 - PubMed
  7. J Asthma. 2000 Jun;37(4):345-51 - PubMed
  8. Lancet. 1997 May 17;349(9063):1436-42 - PubMed
  9. Am Fam Physician. 2003 Nov 1;68(9):1781-90 - PubMed
  10. J Asthma. 2001 Sep;38(6):501-7 - PubMed
  11. Indian J Physiol Pharmacol. 1993 Jul;37(3):213-6 - PubMed
  12. Endocr Pract. 2003 Nov-Dec;9(6):526-9 - PubMed
  13. Eur J Emerg Med. 2003 Sep;10(3):219-24 - PubMed
  14. Ann Intern Med. 1999 Mar 16;130(6):487-95 - PubMed
  15. Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):457-64 - PubMed
  16. Clin Pharmacol Ther. 1979 Feb;25(2):154-60 - PubMed
  17. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):205-10 - PubMed

Publication Types